Skip to main content

Table 4 Estimated mean difference of cytokines serum levels between CC cases and controls stratified by genotypes

From: Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study

Diagnosis

βa coefficient (95 % CI)

Polymorphism

Total without stratification

Ancestral allele homozygote

Heterozygote

Minor allele homozygote

 

IL-4 -590C > T (rs2243250)

 

CC

CT

TT

NCL

 

-

-

-

-

CC

 

1.0 (0.696,1.307)

0.61 (0.269,0.970)

1.22 (0.713,1.736)

0.87 (0.214,1.539)

 

IL-6 -573G > C (rs1800796)

 

GG

GC

CC

NCL

 

-

-

-

-

CC

 

2.63 (2.063,3.199)

3.12 (2.261,3.994)

2.39 (1.567,3.230)

2.20 (0.367,4.042)

 

IL-10 -592C > A (rs1800872)

 

CC

CA

AA

NCL

 

-

-

-

-

CC

 

2.55 (2.255,2.859)

2.27 (1.805,2.737)

2.55 (2.063,3.04)

2.62 (1.911,3.333)

 

IL-10 -819C > T (rs1800871)

 

CC

CT

TT

NCL

 

-

-

-

-

CC

 

2.55 (2.255,2.859)

2.24 (1.760,2.722)

2.45 (1.980,2.927)

2.83 (2.111,3.555)

 

IL-10 -1082A > G (rs1800896)

 

AA

AG

GG

NCL

 

-

-

-

-

CC

 

2.55 (2.255,2.859)

2.48 (2.078,2.898)

2.77 (2.261,3.291)

1.13 (0.508,1.758)

 

IFN-γ -1615C > T (rs2069705)

CC

CT

TT

NCL

 

-

-

-

-

CC

 

−2.58 (−3.286,-1.891)

−2.80 (−3.687,-1.927)

−2.61 (−3.929,-1-291)

−1.7 (−6.097,2.685)

 

TNF-α -308G > A (rs 1800629)

GG

GA

AA

NCL

 

-

-

-

-

CC

 

−0.94 (−1.026,-0.860)

−0.91 (−1.003,-0.816)

−1.08 (−1.30,-0.876)

−1.33 (−1.85,-0.813)

 

TGFB1 -509C > T (rs1800469)

CC

CT

TT

NCL

 

-

-

-

-

CC

 

13.4 (11.52,15.47)

19.5 (15.85,23.17)

11.2 (8.686,13.71)

8.7 (2.54,14.98)

  1. Bold text denotes significant p values (p < 0.05)
  2. aAdjusted by age, CC history and smoking history
  3. Levels of serum cytokines are expressed in pg/ml except TGFB1 (ng/ml)